Suppr超能文献

韩国大疱性类天疱疮患者的死亡率和合并症概况。

Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.

作者信息

Jeon Hyeon Woo, Yun Sook Jung, Lee Seung-Chul, Won Young Ho, Lee Jee-Bum

机构信息

Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Ann Dermatol. 2018 Feb;30(1):13-19. doi: 10.5021/ad.2018.30.1.13. Epub 2017 Dec 26.

Abstract

BACKGROUND

Bullous pemphigoid (BP) is a common autoimmune-mediated blistering skin disease that is significantly associated with mortality and morbidity. However, few studies regarding the mortality and comorbidity profiles of BP have been reported in Korea.

OBJECTIVE

To evaluate and compare the mortality, comorbidity profiles, and risk factors between patients with BP who visited our clinic and an age-matched general population of Korea.

METHODS

We retrospectively evaluated 103 patients diagnosed with BP between 2006 and 2013 at Chonnam National University Hospital in Gwangju, Korea.

RESULTS

The 1-year, 2-year, and 5-year mortality rates of the patients were 18.44%, 28.16%, and 42.00%, respectively. The median age was 76 years (range, 41~96 years). The standardized mortality ratio of patients with BP was 1.83 times that of the age- and sex-matched general population of Korea. Old age at the time of diagnosis, cardiac disease and renal disease were associated with increased 5-year mortality. In addition, the prevalence of diabetes, stroke, dementia, and Parkinson's disease was higher among BP patients than in the general population.

CONCLUSION

The mortality rate of patients with BP is higher than that of the general Korean population. Korean patients with BP are more likely to have dementia, Parkinson's disease, diabetes, and stroke. Risk factors for increased 5-year mortality include old age at the time of diagnosis and medical comorbidities, especially cardiac disease and renal disease.

摘要

背景

大疱性类天疱疮(BP)是一种常见的自身免疫介导的水疱性皮肤病,与死亡率和发病率显著相关。然而,韩国关于BP死亡率和合并症情况的研究报道较少。

目的

评估并比较在我院就诊的BP患者与年龄匹配的韩国普通人群之间的死亡率、合并症情况及危险因素。

方法

我们回顾性评估了2006年至2013年期间在韩国光州全南国立大学医院诊断为BP的103例患者。

结果

患者的1年、2年和5年死亡率分别为18.44%、28.16%和42.00%。中位年龄为76岁(范围41~96岁)。BP患者的标准化死亡率是年龄和性别匹配的韩国普通人群的1.83倍。诊断时年龄较大、心脏病和肾病与5年死亡率增加相关。此外,BP患者中糖尿病、中风、痴呆和帕金森病的患病率高于普通人群。

结论

BP患者的死亡率高于韩国普通人群。韩国BP患者更易患痴呆、帕金森病糖尿病和中风。5年死亡率增加的危险因素包括诊断时年龄较大和合并症,尤其是心脏病和肾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f73/5762471/21b3161cbf98/ad-30-13-g001.jpg

相似文献

1
Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.
Ann Dermatol. 2018 Feb;30(1):13-19. doi: 10.5021/ad.2018.30.1.13. Epub 2017 Dec 26.
2
Mortality of patients with bullous pemphigoid in Korea.
J Am Acad Dermatol. 2014 Oct;71(4):676-83. doi: 10.1016/j.jaad.2014.05.006. Epub 2014 Jun 12.
3
Mortality and prognostic factors of Bullous Pemphigoid in a Moroccan population.
Australas J Dermatol. 2022 Aug;63(3):328-334. doi: 10.1111/ajd.13852. Epub 2022 May 2.
4
Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
An Bras Dermatol. 2014 Mar-Apr;89(2):274-8. doi: 10.1590/abd1806-4841.20142516.
6
Mortality of bullous pemphigoid in Switzerland: a prospective study.
Br J Dermatol. 2011 Aug;165(2):368-74. doi: 10.1111/j.1365-2133.2011.10413.x.
7
Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre.
J Eur Acad Dermatol Venereol. 2014 Apr;28(4):500-6. doi: 10.1111/jdv.12065. Epub 2012 Dec 22.
9
Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Arch Dermatol Res. 2021 Jul;313(5):327-332. doi: 10.1007/s00403-020-02100-2. Epub 2020 Jul 10.

引用本文的文献

1
A Narrative Review of Pemphigoid Diseases: Bridging Associations, Comorbidities, and Management.
Dermatol Ther (Heidelb). 2025 May 24. doi: 10.1007/s13555-025-01444-9.
2
The role of C4d expression in the diagnosis of bullous pemphigoid: a clinical and histopathological study.
Arch Dermatol Res. 2025 Mar 17;317(1):569. doi: 10.1007/s00403-025-04031-2.
3
Clinical Outcomes and Prognostic Factors in Bullous Pemphigoid Patients: A 15-Year Review in China.
Am J Clin Dermatol. 2025 May;26(3):457-470. doi: 10.1007/s40257-025-00925-z. Epub 2025 Mar 10.
4
Bullous pemphigoid.
Nat Rev Dis Primers. 2025 Feb 20;11(1):12. doi: 10.1038/s41572-025-00595-5.
5
Chronic disease associated with bullous pemphigoid risk: A systematic review and meta-analysis.
JAAD Int. 2024 Sep 7;17:141-152. doi: 10.1016/j.jdin.2024.08.010. eCollection 2024 Dec.
6
Comorbidity in bullous pemphigoid: up-date and clinical implications.
Front Immunol. 2023 Jun 29;14:1196999. doi: 10.3389/fimmu.2023.1196999. eCollection 2023.
7
The association between Parkinson's disease and autoimmune diseases: A systematic review and meta-analysis.
Front Immunol. 2023 Jan 25;14:1103053. doi: 10.3389/fimmu.2023.1103053. eCollection 2023.
8
Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China.
Ther Adv Chronic Dis. 2022 Oct 15;13:20406223221130707. doi: 10.1177/20406223221130707. eCollection 2022.
10
Comorbidities in Patients with Autoimmune Bullous Disorders: Hospital-Based Registry Study.
Life (Basel). 2022 Apr 18;12(4):595. doi: 10.3390/life12040595.

本文引用的文献

1
Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.
Br J Dermatol. 2017 Jan;176(1):87-99. doi: 10.1111/bjd.14821. Epub 2016 Oct 29.
2
Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland.
Acta Derm Venereol. 2016 Aug 23;96(6):758-61. doi: 10.2340/00015555-2347.
4
Mortality of bullous pemphigoid in Asia: the same as in Europe?
Br J Dermatol. 2014 Jun;170(6):1216-7. doi: 10.1111/bjd.13016.
5
Mortality of patients with bullous pemphigoid in Korea.
J Am Acad Dermatol. 2014 Oct;71(4):676-83. doi: 10.1016/j.jaad.2014.05.006. Epub 2014 Jun 12.
6
Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.
J Am Acad Dermatol. 2014 Jul;71(1):92-9. doi: 10.1016/j.jaad.2014.02.030. Epub 2014 Apr 3.
8
Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study.
Eur J Dermatol. 2013 Jan-Feb;23(1):94-8. doi: 10.1684/ejd.2012.1906.
9
Mortality of bullous pemphigoid in China.
JAMA Dermatol. 2013 Jan;149(1):106-8. doi: 10.1001/archdermatol.2012.2994.
10
The associations between bullous pemphigoid and drug use: a UK case-control study.
JAMA Dermatol. 2013 Jan;149(1):58-62. doi: 10.1001/2013.jamadermatol.376.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验